Gagnon Advisors’s SomaLogic, Inc. Class A Common Stock SLGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-605,671
Closed -$1.53M 29
2023
Q4
$1.53M Hold
605,671
1.34% 22
2023
Q3
$1.45M Hold
605,671
1.21% 23
2023
Q2
$1.4M Buy
605,671
+92,703
+18% +$262K 0.94% 25
2023
Q1
$1.31M Hold
512,968
0.88% 25
2022
Q4
$1.29M Sell
512,968
-512,968
-50% -$1.43M 0.87% 25
2022
Q3
$2.98M Buy
1,025,936
+512,968
+100% +$2.16M 1.93% 21
2022
Q2
$2.32M Hold
512,968
1.4% 24
2022
Q1
$4.11M Hold
512,968
1.9% 22
2021
Q4
$5.97M Hold
512,968
2.37% 21
2021
Q3
$6.36M Buy
+512,968
New +$5.78M 2.52% 19

Gagnon Advisors's SLGC Position: Q1 2024 in Review

Gagnon Advisors sold out of SomaLogic, Inc. Class A Common Stock (SLGC) in Q1 2024, closing a stake of 605,671 shares — an estimated $1.53M sold.

Gagnon Advisors first reported a position in SLGC in Q3 2021 and held it in 10 quarters. The position peaked at $6.36M in Q3 2021. 0 funds tracked by Wall St. Rank hold SLGC as of Q1 2024.

  • Gagnon Advisors reported no remaining SomaLogic, Inc. Class A Common Stock position as of Q1 2024 after selling out during the quarter.
  • Gagnon Advisors sold 605,671 SomaLogic, Inc. Class A Common Stock shares in Q1 2024, an estimated $1.53M.
  • Gagnon Advisors first reported a position in SomaLogic, Inc. Class A Common Stock in Q3 2021 and held it in 10 quarters.
  • Gagnon Advisors's SomaLogic, Inc. Class A Common Stock position peaked at $6.36M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held SomaLogic, Inc. Class A Common Stock as of Q1 2024.

Based on Gagnon Advisors's 13F filing for Q1 2024, filed 13 May 2024.